These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 3879338)

  • 21. Neurotoxic effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine on striatal biopterin in BALB/c mice.
    Lee EH
    Neurosci Lett; 1988 Jun; 88(3):297-302. PubMed ID: 3260360
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Protection against the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine by monoamine oxidase inhibitors.
    Heikkila RE; Manzino L; Cabbat FS; Duvoisin RC
    Nature; 1984 Oct 4-10; 311(5985):467-9. PubMed ID: 6332989
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Short- and long-term changes in striatal and extrastriatal dopamine uptake sites in the MPTP-treated common marmoset.
    Gnanalingham KK; Milkowski NA; Smith LA; Hunter AJ; Jenner P; Marsden CD
    Eur J Pharmacol; 1995 Apr; 277(2-3):235-41. PubMed ID: 7493614
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Suppression of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced dopaminergic neurotoxicity in mouse brain by piroheptine and trihexyphenidyl.
    Saitoh T
    J Neurol Sci; 1988 Feb; 83(2-3):161-6. PubMed ID: 3258627
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of amphetamine on 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) neurotoxicity in mice.
    Sershen H; Mason MF; Reith ME; Hashim A; Lajtha A
    Neuropharmacology; 1986 Aug; 25(8):927-30. PubMed ID: 3490630
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 4-phenylpyridine and three other analogues of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine lack dopaminergic nigrostriatal neurotoxicity in mice and marmosets.
    Perry TL; Jones K; Hansen S; Wall RA
    Neurosci Lett; 1987 Mar; 75(1):65-70. PubMed ID: 3106859
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dopamine but not norepinephrine or serotonin uptake inhibitors protect mice against neurotoxicity of MPTP.
    Melamed E; Rosenthal J; Cohen O; Globus M; Uzzan A
    Eur J Pharmacol; 1985 Oct; 116(1-2):179-81. PubMed ID: 3876943
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Exposure to cigarette smoke does not decrease the neurotoxicity of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice.
    Perry TL; Hansen S; Jones K
    Neurosci Lett; 1987 Feb; 74(2):217-20. PubMed ID: 3494963
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reversible serotoninergic neurotoxicity of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in mouse striatum studied by neurochemical and immunohistochemical approaches.
    Hara K; Tohyama I; Kimura H; Fukuda H; Nakamura S; Kameyama M
    Brain Res; 1987 May; 410(2):371-4. PubMed ID: 3297254
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in Swiss-Webster mice from different sources.
    Heikkila RE
    Eur J Pharmacol; 1985 Oct; 117(1):131-3. PubMed ID: 3878793
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Parkinsonism-inducing neurotoxin, N-methyl-4-phenyl-1,2,3,6 -tetrahydropyridine: uptake of the metabolite N-methyl-4-phenylpyridine by dopamine neurons explains selective toxicity.
    Javitch JA; D'Amato RJ; Strittmatter SM; Snyder SH
    Proc Natl Acad Sci U S A; 1985 Apr; 82(7):2173-7. PubMed ID: 3872460
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nicotine enhances 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity.
    Behmand RA; Harik SI
    J Neurochem; 1992 Feb; 58(2):776-9. PubMed ID: 1445501
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dopamine uptake blockers protect against the dopamine depleting effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the mouse striatum.
    Ricaurte GA; Langston JW; DeLanney LE; Irwin I; Brooks JD
    Neurosci Lett; 1985 Sep; 59(3):259-64. PubMed ID: 3932903
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characteristics of 1-methyl-4-(2'-methylphenyl)-1,2,3,6-tetrahydropyridine-induced neurotoxicity in the mouse.
    Sonsalla PK; Youngster SK; Kindt MV; Heikkila RE
    J Pharmacol Exp Ther; 1987 Sep; 242(3):850-7. PubMed ID: 2888874
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Partial protection from the dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) by Pro-Leu-Gly-NH2(PLG; MIF-1).
    Sheng JG; Xu DL; Yu HZ; Xu XR; Tang QM
    Life Sci; 1987 May; 40(20):2007-10. PubMed ID: 2437428
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Calcium channel agonist, (+/-)-Bay K8644, causes an immediate increase in the striatal 1-methyl-4-phenylpyridinium level following systemic administration of the dopaminergic neurotoxin, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, in Balb/c mice.
    Samantaray S; Mohanakumar KP
    Neurosci Lett; 2003 Jul; 346(1-2):69-72. PubMed ID: 12850550
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on age-related changes in dopamine turnover and transporter function in the mouse striatum.
    Sershen H; Mason MF; Hashim A; Lajtha A
    Eur J Pharmacol; 1985 Jul; 113(1):135-6. PubMed ID: 3876226
    [No Abstract]   [Full Text] [Related]  

  • 38. Effects of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine and related compounds on the uptake of [3H]3,4-dihydroxyphenylethylamine and [3H]5-hydroxytryptamine in neostriatal synaptosomal preparations.
    Heikkila RE; Youngster SK; Manzino L; Cabbat FS; Duvoisin RC
    J Neurochem; 1985 Jan; 44(1):310-3. PubMed ID: 3871120
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chronic L-deprenyl does not alter the restoration of striatal dopamine in MPTP-lesioned mice.
    Wiener HL; Hashim A; Lajtha A; Sershen H
    J Neurosci Res; 1989 Jul; 23(3):326-9. PubMed ID: 2504936
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The actions of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in animals as a model of Parkinson's disease.
    Jenner P; Marsden CD
    J Neural Transm Suppl; 1986; 20():11-39. PubMed ID: 3091760
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.